Hexagon Nutrition Limited reported a significant improvement in profitability for the first quarter of FY27, with consolidated net profit rising 25% year-on-year to ₹80.73 million. Revenue from operations expanded by 43% to ₹1,043.06 million, reflecting strong top-line momentum following the company’s recent initial public offering (IPO) and listing on Indian stock exchanges in June 2026.

The financial performance was underpinned by a substantial increase in total income, which reached ₹1,063.84 million compared to ₹742.37 million in the corresponding quarter of the previous year. While cost of materials consumed increased to ₹670.86 million from ₹426.15 million, the company benefited from a favorable change in inventories of finished goods and work-in-progress, recording a credit of ₹98.37 million against a credit of ₹75.72 million in Q1FY26.

What the Numbers Show

A notable divergence exists between the standalone and consolidated results regarding revenue growth. Standalone revenue rose 60% to ₹1,014.02 million, outpacing the consolidated growth rate of 43%. This suggests that inter-segment eliminations or lower growth rates in specific subsidiaries may be moderating the group-wide top-line expansion. Additionally, other income declined significantly quarter-on-quarter from ₹39.55 million to ₹20.78 million, indicating that the current quarter’s profit growth was primarily driven by core operational efficiencies rather than non-operating gains.

The Board of Directors, meeting on August 12, 2026, recommended a final dividend of ₹0.30 per equity share of face value ₹1 each for the financial year ended March 31, 2026. The dividend is subject to shareholder approval at the 33rd Annual General Meeting scheduled for September 22, 2026. The record date for determining eligibility has been fixed as September 15, 2026.

Corporate Governance and Strategic Updates

In a move to strengthen its leadership team, the Board appointed Mr. Raghunath Sawant as Additional Executive Director with effect from August 12, 2026. Mr. Sawant, who has been associated with the company since July 2022, holds a Diploma in Food Technology. The Board also recommended the re-appointment of Mr. Arun Purushottam Kelkar as Chairman & Director.

The company disclosed several post-balance sheet events that may impact future operations. Management initiated the phased decommissioning and operational restructuring of its Premix manufacturing facility in Nashik, Maharashtra. This restructuring is expected to result in PPE derecognition and impairment assessments, though no financial impact has been recognized in the Q1FY27 results as it is a non-adjusting event.

Auditors S K Patodia & Associates LLP highlighted material uncertainties regarding two foreign subsidiaries, Hexagon Nutrition Proprietary Ltd (South Africa) and Hexagon Nutrition LLC (Uzbekistan), which reflect a net liability position due to historical accumulated losses. The holding company has committed to providing unconditional financial support to ensure their going concern status.

Hexagon Nutrition reported a financial performance for the year ended March 31, 2026, with revenue from operations reaching ₹382.63 crore. The company achieved an EBITDA of ₹52.90 crore, reflecting a margin of 13.83%, while Profit After Tax (PAT) stood at ₹37.94 crore, a PAT margin of 9.9%. For the fourth quarter, revenue was ₹115.04 crore with a PAT of ₹10.9 crore. The financial results were disclosed via an earnings call transcript filed under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance

The company demonstrated strong growth metrics with a PAT CAGR of 76.2% between FY24 and FY26. EBITDA margins improved significantly from 6.2% in FY23 to 13.83% in FY26. Return on Capital Employed (ROCE) for FY26 was recorded at 20.94%, up from 5.94% in FY23, while Return on Equity (ROE) rose to 17.75% from 3.5% in the same period.

Segment Performance and Margins

Management provided insights into segment-wise margins during the earnings call. The branded segment operates with margins between 60% and 68%, the premix segment between 35% and 40%, and the ESG segment between 25% and 30%. For FY26, the branded business accounted for 30% of revenue, the premix segment 35% to 40%, and the ESG segment 30%. The improvement in EBITDA margins was attributed to volume growth in the branded segment and support from the premix business.

Balance Sheet Strength

Hexagon Nutrition maintained a robust balance sheet with a debt-to-equity (D/E) ratio of 0.13x, down from 0.32x in FY23. The company reported net debt of (₹145) Mn, indicating a net cash positive position. The current ratio stood at 3.38x, and interest coverage improved to 13.6x, compared to 3.82x in FY23. Trade receivables increased to ₹82 crore from ₹60 crore in the previous year, primarily due to large orders dispatched in the ESG and domestic premix segments during the latter half of the year.

Operational Metrics

The company operates four manufacturing plants located in Nashik, Chennai, Thoothukudi, and Uzbekistan. Total capacity utilization was approximately 30% for the year ended December 2025, with management expecting utilization to range between 35% and 40% going forward. The branded business operates at 50% to 60% capacity, the premix business at 40% to 45%, and the ESG business varies between 35% and 60% depending on order flow. Export revenue constituted 57% of the total revenue for the fiscal year.